Why is the Resmed (ASX: RMD) share price up 13% this week?
Resmed Inc (ASX: RMD) reported Q3 earnings overnight, on Thursday 25 April, sending RMD shares in its US up +11% after-hours.
Resmed Inc (ASX: RMD) reported Q3 earnings overnight, on Thursday 25 April, sending RMD shares in its US up +11% after-hours.
The Resmed (ASX:RMD) share price has climbed 7% after the ASX healthcare share revealed its performance for the three months to March 2024.
The S&P/ASX 200 (INDEXASX: XJO) caught up with the global pullback last week, with a loss of 2.8%.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.81% to 7,612.
The S&P/ASX 200 (INDEXASX: XJO) pulled back 1.6% last week in line with global trends -while bond yields edged higher.
The S&P/ASX 200 (INDEXASX: XJO) delivered another positive day, gaining 0.3 per cent ahead of key US inflation data.
The All Ordinaries (INDEXASX: XAO) posted another positive day despite growing pressure from a renewed surge in bond yields towards 4.2%.
The Fisher & Paykel Healthcare Ltd (ASX:FPH) share price has fallen after announcing a product recall for two of its devices.
Here’s today’s latest S&P/ASX 200 (INDEXASX: XJO) market update by Drew Meredith, CFP, from Wattle Partners: Woolworths Group Ltd (ASX: WOW) and Coles Group Ltd (ASX: COL) added more than 1 per cent as signs of stable inflation meant hopes for stronger profit margins improved.
Resmed Inc (ASX: RMD) reported Q3 earnings overnight, on Thursday 25 April, sending RMD shares in its US up +11% after-hours.
The Resmed (ASX:RMD) share price has climbed 7% after the ASX healthcare share revealed its performance for the three months to March 2024.
The S&P/ASX 200 (INDEXASX: XJO) caught up with the global pullback last week, with a loss of 2.8%.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.81% to 7,612.
The S&P/ASX 200 (INDEXASX: XJO) pulled back 1.6% last week in line with global trends -while bond yields edged higher.
The S&P/ASX 200 (INDEXASX: XJO) delivered another positive day, gaining 0.3 per cent ahead of key US inflation data.
The All Ordinaries (INDEXASX: XAO) posted another positive day despite growing pressure from a renewed surge in bond yields towards 4.2%.
The Fisher & Paykel Healthcare Ltd (ASX:FPH) share price has fallen after announcing a product recall for two of its devices.
Here’s today’s latest S&P/ASX 200 (INDEXASX: XJO) market update by Drew Meredith, CFP, from Wattle Partners: Woolworths Group Ltd (ASX: WOW) and Coles Group Ltd (ASX: COL) added more than 1 per cent as signs of stable inflation meant hopes for stronger profit margins improved.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024